Novo Nordisk news
The latest Novo Nordisk news, : OpenAI acquires Orchestra Bio to expand Rosalind life sciences tools.
5 stories mentioning Novo Nordisk since 18 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
OpenAI acquires Orchestra Bio to expand Rosalind life sciences tools
OpenAI announced on October 20, 2026, that it has acquired Orchestra Bio, a startup founded around 2022 that builds AI agents to help pharmaceutical companies manage drug development programs. The Orchestra team and…
19 sourcesfinance.yahoo.comThe Decodernote.comvectorwire.ai +7 more -
Anthropic invests $100M to train 10,000 deployed AI engineers by 2027
Anthropic announced a $100 million initiative to train 10,000 engineers as Frontier Deployed Engineers (FDEs) by the end of 2027. The program, a mix of on-site intensives and 12-week residencies, targets professionals…
3 sourcesCNBC Technologynote.combusinessinsider.com -
ExodusPoint integrates Anthropic’s Claude into its Atlas AI platform for hedge fund workflows
ExodusPoint Capital Management, a multistrategy hedge fund, is partnering with Anthropic to embed its AI agent Claude into its internal Atlas AI platform. The move follows a trend of Wall Street firms adopting…
2 sourcesseekingalpha.comcryptobriefing.com -
Anthropic partners with Novo Nordisk to use Claude models in drug discovery
Anthropic has partnered with Novo Nordisk to use Claude models and Claude Science in Novo's research and development workflows, focusing on scientific problems where AI can have the greatest impact. Novo will also use…
3 sourcesfinance.yahoo.compopularmechanics.comnote.com -
Novo partners with Anthropic on Claude Science platform, shares up 3.55%
Novo Nordisk announced a strategic collaboration with Anthropic to use the Claude Science platform for accelerating pharmaceutical research and development. The partnership was disclosed alongside a 3.55% rise in…
1 sourceblockonomi.com
Questions about Novo Nordisk
What is the latest Novo Nordisk news?
As of 20 October 2026: OpenAI acquires Orchestra Bio to expand Rosalind life sciences tools. OpenAI announced on October 20, 2026, that it has acquired Orchestra Bio, a startup founded around 2022 that builds AI agents to help pharmaceutical companies manage drug development programs.